Hematology-OncologyRelapse Risknon-transplant therapy
Relapse and Survival Benchmarks in Non-Transplanted AML Patients Achieving First Complete Remission
By MedXY|Aug 17, 2026
A retrospective study delineates relapse risks and survival outcomes in adult acute myeloid leukemia patients who achieve first complete remission without undergoing allogeneic stem cell transplantation, highlighting venetoclax’s role in re